MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

105.52 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,224
Open 105.52
Bid (Size) 105.21 (100)
Ask (Size) 106.00 (200)
Prev. Close 105.52
Today's Range 105.52 - 105.52
52wk Range 81.97 - 137.49
Shares Outstanding 1,750,942,289
Dividend Yield 2.39%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
If a Stock Market Crash Is Coming, Investors Will Want to Own This Dividend King ↗
Worried about a pullback? This Dividend King pairs a 54-year streak with catalysts that could provide income even if the market crashes. 
Via The Motley Fool
News headline image
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It ↗
Moderna, Pharvaris and AbbVie span short, mid and long-term healthcare setups, from melanoma data to a Phase 3 catalyst and 13 straight years of dividend hikes. 
Via MarketBeat
Topics Artificial Intelligence Bonds

Performance

YTD
-15.0%
-15.0%
1 Month
-2.9%
-2.9%
3 Month
+15.6%
+15.6%
6 Month
-4.5%
-4.5%
1 Year
-20.2%
-20.2%

More News

Read More
News headline image
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King) ↗
Via The Motley Fool
Topics Intellectual Property
Abbott Laboratories (NYSE:ABT) Clears All Quality Investing Hurdles ↗
Via Chartmill
Abbott Laboratories (NYSE:ABT): A Strong Candidate for Quality Investors ↗
Via Chartmill
News headline image
If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term Portfolio ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Just Starting Out With $5,000? 3 Magnificent ETFs to Buy in 2026. ↗
Via The Motley Fool
Topics ETFs
News headline image
Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy. ↗
Via The Motley Fool
News headline image
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead. ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? ↗
Via The Motley Fool
Topics Lawsuit
News headline image
Recent Report Shows That Rep. Rick Allen Sold Up to $50K Worth of Abbott Laboratories Stock ↗
Via Benzinga
News headline image
If You Invest $100 a Month in SCHD, Here's the Passive Income It Could Deliver in 20 Years ↗
Via The Motley Fool
Topics ETFs Retirement Stocks
News headline image
Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Stock ↗
Via Benzinga
News headline image
The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better. ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Recession-Proofing Your Portfolio Before the Storm Hits ↗
Via The Motley Fool
Topics Economy
News headline image
The U.S. Labor Market Is Weakening. These 2 Dividend Stocks Look Built to Weather a Recession ↗
Via The Motley Fool
Topics Economy
News headline image
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? ↗
Via The Motley Fool
News headline image
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Solventum Nears Inflection Point As It Begins to Unlock Value ↗
Via MarketBeat
Topics Initial Public Offering
News headline image
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
3 Dividend Stocks to Buy for a Lifetime of Passive Income ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Why Wall Street Can't Get Enough of This Dividend King ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 105.52
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 09/08/26 07:00 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 184.76B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 185B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story